Standout Papers

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and my... 2010 2026 2015 2020 1.4k
  1. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors (2010)
    Michael A. Curran, Hideo Yagita∥ et al. Proceedings of the National Academy of Sciences
  2. PD-L1 Expression in Triple-Negative Breast Cancer (2014)
    Elizabeth A. Mittendorf, Anne V. Philips et al. Cancer Immunology Research
  3. Development of Immunotherapy Combination Strategies in Cancer (2021)
    Timothy A. Yap, Eileen E. Parkes et al. Cancer Discovery

Immediate Impact

78 by Nobel laureates 14 from Science/Nature 129 standout
Sub-graph 1 of 14

Citing Papers

Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
2022 Standout
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
1 intermediate paper

Works of Michael A. Curran being referenced

Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
2017
4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity
2015

Author Peers

Author Last Decade Papers Cites
Michael A. Curran 3553 3866 1628 124 6.7k
Philipp Beckhove 4909 4746 1805 150 8.1k
Pierre‐Yves Dietrich 3268 2625 2454 172 7.3k
Claudia Palena 3010 3426 1872 93 5.9k
Sumit K. Subudhi 3532 3887 1429 105 7.0k
María E. Rodríguez-Ruiz 3470 3913 1306 89 6.1k
Miguel F. Sanmamed 4895 5458 2490 115 9.0k
Marc Schmitz 3156 2775 2003 171 6.2k
Siwen Hu‐Lieskovan 4205 5877 2912 90 8.7k
Fathia Mami‐Chouaib 4736 3678 2137 106 7.7k
John S. Yu 3112 4120 3283 167 8.6k

All Works

Loading papers...

Rankless by CCL
2026